SEC Form 4 · accession 0001209191-16-141587
Protagonist Therapeutics, Inc · PTGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Chaitan Khosla Ph.D.
Director
Period of report
Sep 13, 2016
Accepted (ET)
Sep 15, 2016 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001377121
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $12.88 | Sep 13, 2016 | A | 24,000 | A | — | Sep 13, 2026 | Common Stock | 24,000 | 24,000 | D |
Explanation of responses
- F1The shares subject to the option shall vest in equal monthly installments over a three-year period from the vesting commencement date of August 10, 2016.